153660-03-8 (2-羟基-6-甲基嘧啶-4-羧酸乙酯,Sp-8-Br-cGMPS)

2-羟基-6-甲基嘧啶-4-羧酸乙酯;

Guanosine, 8-bromo-,cyclic 3',5'-[hydrogen (S)-phosphorothioate] (9CI);8- BROMOGUANOSINE- 3', 5'- CYCLIC MONOPHOSPHOROTHIOATE, SP- ISOMER ( SP-8-BR-CGMPS );sodium,2-amino-8-bromo-9-[(6R)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-3H-purin-6-one;SP-8-BR-CGMPS;8-BR-CGMPS NA, SP-ISOMER;SP-8-BR-CGMPS SODIUM SALT;SP-8-BROMOGUANOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, SODIUM SALT;8-BROMOGUANOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE, SP-ISOMER SODIUM SALT;8-Bromoguanosine-3'',5''-cyclic monophosphothioate sodium salt Sp isomer;8-BROMOGUANOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE SODIUM SALT, SPISOMER;8-BROMOGUANOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, SP-ISOMER SODIUM SALT;8-BROMOGUANOSINE3,5-CYCLICMONOPHOSPHOTHIOATESP-ISOMERSODIUMSALT,HIGHPURITY;GUANOSINE 3',5'-CYCLIC MONOPHOSPHOROTHIOATE, 8-BROMO-, SP-ISOMER, SODIUM SALT;Sodium (6R)-6-(2-amino-8-bromo-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxy-2-sulfanylidenetetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate;sodium;2-amino-8-bromo-9-[(6R)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-1H-purin-6-one;DTXSID30849601;J-009040;153660-03-8;

CHTSSROWUAICIL-YKHKOMLCSA-M

1S/C10H11BrN5O6PS.Na/c11-9-13-3-6(14-10(12)15-7(3)18)16(9)8-4(17)5-2(21-8)1-20-23(19,24)22-5;/h2,4-5,8,17H,1H2,(H,19,24)(H3,12,14,15,18);/q;+1/p-1/t2?,4?,5?,8-,23?;/m1./s1

BrC1=NC2C(NC(N)=NC=2N1[C@H]1C(C2C(COP([O-])(O2)=S)O1)O)=O.[Na+]